surfaces such as the peritoneum, thus forming new tumor bulk, and induction of angiogenesis. 5 For these tissue remodeling processes, dynamic rearrangement of cell-cell junctions is essential. In this context, adhesion proteins of different cell junctions such as adherens junctions (AJ) and tight junctions (TJ) may play a distinct role.
The nectin-afadin system has recently been described as a novel modulator of AJ and TJ, 6 acting as a cooperator system of AJ and TJ regulation. 7, 8 The nectins comprise a family of Ca 2+ -independent immunoglobulin-like cell adhesion molecules consisting of at least four members (nectin 1-4). [9] [10] [11] [12] [13] [14] Nectins are associated with the actin cytoskeleton through afadin, an F-actin-binding protein [15] [16] [17] forming homophilic and heterophilic trans-dimers. 7 Thereby, they function as cell-cell adhesion molecules and regulate the initial step of cell-cell junction formation of both AJ and TJ in epithelial and endothelial
cells. Nectin-2-also termed cluster of differentiation 112 (CD112)
and poliovirus receptor-related protein 2-is a transmembrane glycoprotein that interacts with various Nectin-like (Necl) molecules and different scaffold proteins regulating cellular functions such as proliferation cell movement, survival, cell adhesion and differentiation. 18 These functions of Nectin-2 implicate its possible role in tumor cell survival and proliferation. So far, although only few investigations exist, the involvement of Nectin-2 in tumor pathogenesis has been described for different tumor entities, such as breast and ovarian cancer, but also for gallbladder, colorectal or pancreatic cancer. [19] [20] [21] In some of these studies, high expression of Nectin-2 was associated with high malignancy, advanced tumor stage, poor differentiation, fast progression and poor outcome/prognosis. [20] [21] [22] At the same time, inhibition of Nectin-2 was followed by ceasing proliferation of tumor cells in cell culture. These studies indicate the high potential of Nectin-2 as a target for antibody therapeutics.
Despite its potential role in tumor cells, Nectin-2 has also been described as a surface marker of endothelial cells which-as an adhesion protein-might be involved in the regulation of endothelial migration, proliferation and permeability. 18 Here, vascular endothelial growth factor (VEGF; and its interaction with adhesion molecules) is known to be the key regulator of angiogenesis and permeability regulation. 23 Our previous investigations have shown that increased peritoneal vascular permeability is due to VEGF-induced suppression of adhesion molecules in the peritoneal vasculature of ovarian cancer patients and is followed/associated with ascites production. 24 To further elucidate the potential role of Nectin-2 in ovarian cancer as well as its interaction and association with VEGF, we investigated the expression of Nectin-2 in human ovarian cancer tissue, which was collected over a period of 6 years from patients undergoing surgery compared to controls. Furthermore, we analyzed differences in expression concerning tumor biology, tumor stage, histological subtype, nodal metastasis, grading, estrogen/progesterone receptor expression and resection status after surgery as well as survival. As this cancer entity is frequently associated with increased vascular permeability of the peritoneum driven by tumorderived VEGF, peritoneal biopsies of ovarian cancer patients were collected and Nectin-2 protein localization and gene expression investigated. Furthermore, serum levels of VEGF were measured in tumor patients and controls to evaluate systemic VEGF interaction.
Finally, the potential impact of VEGF on Nectin-2 expression in endothelial cells was tested in vitro. 
| MATERIAL SANDME THODS

| Patients
| PreparationoftissueforH&Estainingand immunohistochemistry
Tumor and peritoneal tissue samples were fixed in 3.5%-3.7% formaldehyde (Fischar) for 24 hours and then incubated in 70% ethanol at room temperature overnight. Afterwards the tissue was dehydrated for each 2 × 45 minutes at 40°C in ascending concentrations of ethanol (95%-100%). Then tissue samples were placed in xylol and incubated for 2 x 45 minutes, followed by incubation in Paraplast Plus (Tissue Embedding Medium, Leica, Richmond, VA, USA) at 60°C
for 2 x 60 minutes.
| Morphologicalcharacterizationofovarian cancer
Consecutive sections stained for H&E were used to classify the ovarian cancer and peritoneal tissue. Therefore, the embedded samples were serially sectioned, and tissue sections (3 μm) were placed onto 
| Immunhistochemistryforspecificcancer cellmarkers
| Immunohistochemistrydualstainingof Nectin-2andCD31
Immunofluorescence double-staining was carried out using a TSA- 
| Imageanalyses
Quantitative analysis of immunostaining was carried out in randomly 
| QuantificationofVEGFbyELISA
Analysis of our study focused on the most important pro-angiogenic Tecan, Männedorf, Switzerland).
| EndothelialcellisolationofHUVEC
Collection of human primary cells was institutionally approved after favorable ethical review. Human umbilical cords were rinsed with water and disinfected with isoseptol. Under sterile conditions the ends of the cords were cut and, into each end, a flexible tube was inserted and fixed with a cable tie. The umbilical veins were rinsed with PBS (1 × PBS). One end was clamped and, from the other end, the vein was filled with Type I-A collagenase 1 mg/mL (100 mg;
Sigma, Saint Louis, MO, USA) to detach the endothelial cells.
Subsequently, the second end was clamped and the cords were incubated in 1 × PBS in a water bath at 37°C for 15 minutes. HUVEC were collected and mixed 1:1 with endothelial cell growth medium (C-22010; PromoCell, Heidelberg, Germany) + 10% FCS with 1%
penicillin/streptomycin (Gibco Life Technologies, Carlsbad, CA, USA). After centrifugation for 5 minutes at 290 g, the supernatant was discarded and the pellet was resuspended in culture medium.
HUVEC were seeded in Primaria tissue flasks (25 cm 2 ) (BD Falcon, Bedford, MA, USA) and incubated at 37°C in 5% CO 2 .
| StimulationandRNAisolationofHUVEC
Endothelial cells were stimulated in six-well plates for 48 hours with 500 ng/mL VEGF alone, 5000 ng/mL Flt-1/Fc alone and 500 ng/mL VEGF + 5000 ng/ 
| PreparationoftissueforRNAisolation
Pulverized tumor and peritoneal tissue (50-100 mg) was mixed with 
| Humanovariansurfaceepithelialcellsand reversetranscription
As control for our tumor samples, Human Ovarian Surface Epithelial
Cell total RNA (HOSEpiC #7315; 3H Biomedical, Uppsala, Sweden) already prepared by manufacturer from early passage human ovarian surface epithelial (OSE) cells using the Qiagen AllPrep DNA/RNA Mini kit) was used and reverse transcribed into cDNA.
Total RNA (1.0 μg) was reverse transcribed into cDNA using the High Capacity cDNA Reverse Transcription Kit (Applied Biosystems, Foster City, CA, USA) according to the manufacturer's instructions.
| Real-time-PCR
For quantification of Nectin-2 expression, TaqMan Gene Expression Assays for Nectin-2 (Hs01071562) was used according to the manufacturer's instructions using TaqMan Universal PCR Master
Mix (Applied Biosystems/Life Technologies, Darmstadt, Germany).
Amplification and detection of specific products was carried out with ViiA 7 Real-Time PCR System (Applied Biosystems/ Life Technologies). As internal controls, two housekeeping genes HSP90AB1 (Hs01546471_g1) and β2-microglobolin (Human B2M;
Applied Biosystems) were used and the quantity of cDNA was normalized to the quantity of both cDNAs in each sample. Calculation of relative gene expression was done using the comparative 2 −ΔΔCT method. 26 This method made it possible to determine the fold change in gene expression compared to control and create linear data from exponential values.
| SmallinterferingRNAknockdownof Nectin-2
For our knockdown experiments 1 day before transfection, 8 × 10 
| Permeabilityassay(inknockdown experiments)
To test the permeability of endothelial cells for macromolecules, HUVEC were seeded into an insert to allow the flow of dye through the membrane. HUVEC were seeded on micropore inserts (pore size 0.4 μm) at a density of 3 × 10 5 cells per insert and cultured overnight.
The next day, BSA was labeled with Trypan blue (66.7 mg Trypan blue to 1.6 g BSA in 40 mL PBS), mixed with culture medium 1:1, and added to the insert, whereas unlabeled albumin was added to the lower compartment. Samples of the wells were taken after 10 and 30 minutes and measured for color intensity at 607 nm. Each experiment was repeated on three separate occasions.
| Statisticalanalysis
Statistical analysis was carried out using SPSS for Windows version All statistical tests were two-tailed and P values below .05 were considered to be statistically significant.
| RE SULTS
| Patientsandhistopathologicalcharacteristics
In total, 60 patients with ovarian cancer and 20 healthy control biopsies were collected over a period of 6 years with a follow-up period . Of all patients, 72% fulfilled the criteria for lymphadenectomy. Of these patients 29% were nodal negative and 71% were nodal positive.
Patients with advanced tumor stage (T3) had a significantly higher
percentage of positive lymph nodes than patients with early tumor stage (T1) (P = .037; Figure 2A ). Patients who died from ovarian cancer had a significantly higher percentage of positive lymph nodes than patients who are still alive (P = .009; Figure 2B ). Table 1 summarizes the histopathological characteristics of the enrolled patients.
| Nectin-2proteinlocalizationandquantification inovariancancerandperitonealbiopsies
In nearly all of our tumor biopsies, Nectin-2 protein was localized in the plasma membrane of cancer cells ( Figure 3 ) which was identified by tumor cell markers as described earlier. Staining was particularly evident in regions in which the tumor still mimicked a glandular appearance, whereas other regions with tumor cell bulk lacked any Nectin-2 staining ( Figure 3F ). CD31/Nectin-2 dual staining was found only for a few capillaries, indicating that the main source of protein synthesis of Nectin-2 are the tumor cells themselves ( Figure 3G ).
In the peritoneal biopsies, Nectin-2 was clearly localized in the endothelium of the peritoneal vasculature ( Figure 4 ). In controls, staining appeared as a continuous inner circle of the vessel ( Figure 4F,G) . In peritoneal vasculature of tumor patients, this continuous circle is disrupted and dual staining was only evident in a few parts of the vessel. Quantitative analysis confirmed a significant decrease in these vessels in comparison to control (ie, 62.1% ± 6.1% vs 91.1% ± 2.0% [P = .05]).
| Nectin-2geneexpressioninovariancancer biopsies
Comparison of Nectin-2 gene expression in tumor biopsies of our ovarian cancer patients with control (ovarian surface epithelium)
showed higher expression levels in the tumor biopsies ( Figure 5A ).
There were no significant detectable differences between histological subtypes ( Figure 5B ), grading, receptor status or distant metastasis.
However, we found significantly higher gene expression of Nectin-2 in tumor biopsies of patients with lymph node metastasis as compared to nodal negative patients (P = .018; Figure 5C ).
In ovarian cancer biopsies of women in which the tumor was successfully removed during surgery (TR 0), Nectin-2 expression was lower as compared to women with an incomplete resection of the tumor (TR 1 or TR 2). This difference was significant (P = .018) for patients with >1 cm residual tumor after surgery (TR 2) in comparison to patients with no residual tumor ( Figure 5D ).
| Nectin-2geneexpressioninperitoneal endotheliumandVEGFserumlevelsincancer patientsincomparisontocontrols
In the peritoneal endothelium, Nectin-2 expression was significantly decreased (P = .013) in tumor patients compared to controls ( Figure 6A ). At the same time, VEGF was significantly increased (P = .01) clearly shown in the serum samples of tumor patients as compared to the serum levels of controls ( Figure 6B ).
No significant differences of Nectin-2 expression in peritoneal
endothelium or serum VEGF levels were detectable regarding different histological subtypes, grading, nodal status or distant metastasis
(not shown).
| Nectin-2geneexpressioninendothelialcells, afterVEGFstimulation,andVEGFinhibitionwith Flt-1/FcinHUVECculture
To further elucidate the degree to which VEGF affects Nectin-2 expression in endothelial cells, HUVEC were stimulated with VEGF, and
Nectin-2 gene expression was measured. After treatment, Nectin-2 TA B L E 1 Baseline patient and tumor characteristics of all 60 ovarian cancer patients randomized in the present study expression was significantly downregulated (P < .001). This effect was significantly reversed by simultaneous inhibition of VEGF by Flt-1/Fc (P < .001). Interestingly, Nectin-2 expression after VEGF inhibition was significantly even higher (P < .001) as compared to Nectin-2 gene expression in control endothelium (HUVEC; Figure 7A ).
| EffectofknockdownofNectin-2inHUVECon endothelialpermeability
To investigate the effect of Nectin-2 on permeability regulation, we carried out knockdown experiments by quantifying the relative 
| D ISCUSS I ON
Ovarian cancer is mostly diagnosed in an advanced stage of tumor. 
27,28
In the present study, we localized Nectin-2 in the tumor cells of ovarian cancer biopsies and found that Nectin-2 is highly expressed in ovarian cancer patients especially in nodal-positive patients and in those with >1 cm residual tumor after surgery (TR 2), namely patients who are known to be associated with a poor outcome. 27 A possible interpretation of this observation might be that tumor cell spread and dissemination into the abdominal cavity may be supported by increased peritoneal permeability as a result of downregulation of capillary adhesion proteins such as Nectin-2 in the peritoneal vasculature as shown in this study.
Recent studies have indicated that for local tumor spread into the abdominal cavity and to the peritoneal tissue, tumor cell migration and adhesion are the main mechanisms involved. 29 Although very few studies are available, molecules such as Nectins are described to be involved in these processes. 8, 17 These functions of Nectins implicate its possible roles in tumor cell survival and proliferation. In our study, we localized Nectin-2 protein mostly in the tumor cells in our human ovarian cancer biopsies and found higher gene expression of Nectin-2 in tumor cells of ovarian cancer patients in comparison to controls (ovarian surface epithelium). This observation is in line with investigations by Oshima et al. 20 By using expression profile analysis, the authors showed overexpression of Nectin-2 in ovarian cancer tissue as compared to healthy controls. Moreover, recent studies have shown that Nectin-2 is highly expressed in epithelial malignancies and it was suspected that the expression correlates with high malignancy, fast progression, and/or poor prognosis of human breast cancer 19 or gallbladder cancer. 21 It was also demonstrated that inhibition of Nectin-2-using monoclonal antibodiessuppressed tumor cell proliferation in vitro. 20 The hypothesis that and survival factor for this tumor entity. 27, 32, 33 In our study, patients in whom complete removal of the tumor was achieved showed significantly lower Nectin-2 expression in tumor biopsies as compared to patients in which a tumor residual of more than 1 cm remained.
These results suggest that high tumor Nectin-2 expression in ovarian cancer may account for aggressive tumors and those associated with poor prognosis.
A second aspect of Nectin-2 functioning as a promotor of tumor cell spread may be seen in its potential involvement in ascites production. Ascites formation in ovarian cancer is known to facilitate the dissemination of cancer cells into the abdominal cavity. 34 In our previous investigations, we showed that increased peritoneal vascular permeability is due to VEGF-induced suppression of adhesion molecules in the peritoneal vasculature. 24 Furthermore, we showed that VEGF-derived ascites formation increases with aggressive ovarian cancer subtypes. 29 In the current study, we found Nectin-2 localized in the peritoneal vasculature. This is in line with the results of our previous studies where colocalization of the adhesion proteins claudin 5 and VE-cadherin, as well as decreased expression in the peritoneum of ovarian cancer patients, was found. 24, 29 In the current experiment, Nectin-2 was clearly suppressed in the peritoneal endothelium of tumor patients as compared to controls, associated with highly expressed VEGF in the tumor and increased VEGF serum levels indicating that Nectin-2 downregulation might be VEGF driven.
In our cell culture experiments, VEGF stimulation of endothelial cells resulted in significant downregulation of Nectin-2 that was not only reversed by simultaneous VEGF inhibition, but was also followed by significantly increased Nectin-2 expression as compared to controls. This interesting observation may be explained by additional suppression of endogenous VEGF synthesized by the endothelial cells themselves. Moreover, our finding that Nectin-2 knockdown in endothelial cells significantly increased endothelial permeability further supports the hypothesis that Nectin-2 plays a role in the regulation of permeability in the peritoneum. Taking these results together, it can be assumed that downregulation of Nectin-2
by VEGF, together with other adhesion proteins, supports the increase in vascular permeability to allow ascites production for local tumor dissemination. So far, it is not clear whether this is a direct effect of VEGF or whether the effect is indirectly achieved by downregulation of other adhesion proteins. In earlier studies, we showed that adhesion proteins influence each other. Knockdown of claudin 5 or VE-cadherin resulted in suppression of one or the other, respectively, and of Nectin-2 in vitro. 35 Both effects were associated with increased endothelial permeability. In the present study, we found that knockdown of Nectin-2 in HUVEC was followed by an increase in permeability, indicating that Nectin-2 is either directly or indirectly regulated by VEGF and, in this way, involved in permeability regulation that may facilitate local tumor spread into the abdominal cavity.
In summary, herein we showed that high expression of Nectin-2 in tumor cells of ovarian cancer patients is associated with early lymph node metastasis and residual tumor after surgery (TR 2), resulting in a poor outcome for the patient. Downregulation of Nectin-2 in the peritoneal vasculature through the function of VEGF may increase vascular permeability followed by ascites production that further facilitates tumor dissemination in the abdominal cavity.
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